Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer - Rosell, Rafael; Filipska, Martyna; Chaib, Imane; Lligé, David; Laguia, Fernando (Frontiers in Oncology, 2020)